Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,328,969
+$3,105,356 QoQ
Shares Held
9,193
+1224.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,019
of 3,140 holders
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nilsine Partners, LLC holds $35,772,221 across 11 Drug Manufacturers - General names. AMGN ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,082 | $13,292,084 | |
| 2 | JNJ |
Johnson & Johnson
|
23,855 | $6,058,454 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,144 | $3,359,504 | |
| 4 | NVO |
Novo Nordisk A S
|
69,503 | $3,331,973 | |
| 5 | AMGN |
Amgen Inc
This page
|
9,193 | $3,328,969 | |
| 6 | ABBV |
AbbVie Inc.
|
10,103 | $2,542,318 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
16,624 | $2,100,276 | |
| 8 | NVS |
Novartis AG
|
4,809 | $753,666 |
All Filings in AMGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,328,969 | 9,193 | Shares | Sole | 2026-07-24 | |
| 2024-09-30 | $223,613 | 694 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $233,400 | 747 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||